Search research articles
Contact Us
Filters
Showing results (201-210 of 269) with videos related to
Page
of 27
Sort By:
The American Journal of Cardiology
|
October 22, 1998
Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris
H Benamer, P G Steg, J Benessiano, et al.
Clinical Cardiology
|
July 18, 2019
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
Fabien Picard, Eric Van Ganse, Gregory Ducrocq, et al.
European Journal of Preventive Cardiology
|
August 23, 2013
Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry
G Ducrocq, D L Bhatt, J Labreuche, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 14, 2016
Editor's Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease
Laurent Feldman, Philippe G Steg, Myriam Amsallem, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 8, 2015
ST-segment resolution with bivalirudin versus heparin and routine glycoprotein IIb/IIIa inhibitors started in the ambulance in ST-segment elevation myocardial infarction patients transported for primary percutaneous coronary intervention: The EUROMAX ST-segment resolution substudy
Arnoud Van't Hof, Francesco Giannini, Jurrien Ten Berg, et al.
The American Journal of Cardiology
|
June 11, 1999
Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment
S P Marso, G Steg, T Plokker, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 6, 2016
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy
Evangelos Giannitsis, Lars Wallentin, Stefan K James, et al.
International Journal of Cardiology
|
November 30, 2010
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL
C Ceconi, S B Freedman, J C Tardif, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach
J M Kittelson, A C Spyropoulos, J L Halperin, et al.
Heart Asia
|
June 22, 2016
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry
S Goto, Y Ikeda, J C N Chan, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 269) with videos related to
Sort By:
Page
of 27
The American Journal of Cardiology
|
October 22, 1998
Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris
H Benamer, P G Steg, J Benessiano, et al.
Clinical Cardiology
|
July 18, 2019
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
Fabien Picard, Eric Van Ganse, Gregory Ducrocq, et al.
European Journal of Preventive Cardiology
|
August 23, 2013
Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry
G Ducrocq, D L Bhatt, J Labreuche, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 14, 2016
Editor's Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease
Laurent Feldman, Philippe G Steg, Myriam Amsallem, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 8, 2015
ST-segment resolution with bivalirudin versus heparin and routine glycoprotein IIb/IIIa inhibitors started in the ambulance in ST-segment elevation myocardial infarction patients transported for primary percutaneous coronary intervention: The EUROMAX ST-segment resolution substudy
Arnoud Van't Hof, Francesco Giannini, Jurrien Ten Berg, et al.
The American Journal of Cardiology
|
June 11, 1999
Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment
S P Marso, G Steg, T Plokker, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 6, 2016
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy
Evangelos Giannitsis, Lars Wallentin, Stefan K James, et al.
International Journal of Cardiology
|
November 30, 2010
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL
C Ceconi, S B Freedman, J C Tardif, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 19, 2013
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach
J M Kittelson, A C Spyropoulos, J L Halperin, et al.
Heart Asia
|
June 22, 2016
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry
S Goto, Y Ikeda, J C N Chan, et al.
Page
of 27